 | • レポートコード：MRC2-11QY00244 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はコレステロール低下生物学的薬剤のグローバル市場について調査・分析したレポートです。種類別（経口投与用、注射薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、オンライン販売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別コレステロール低下生物学的薬剤の競争状況、市場シェア ・世界のコレステロール低下生物学的薬剤市場：種類別市場規模 2015年-2020年（経口投与用、注射薬） ・世界のコレステロール低下生物学的薬剤市場：種類別市場規模予測 2021年-2026年（経口投与用、注射薬） ・世界のコレステロール低下生物学的薬剤市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、オンライン販売） ・世界のコレステロール低下生物学的薬剤市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、オンライン販売） ・北米のコレステロール低下生物学的薬剤市場分析：米国、カナダ ・ヨーロッパのコレステロール低下生物学的薬剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのコレステロール低下生物学的薬剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のコレステロール低下生物学的薬剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのコレステロール低下生物学的薬剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、Regeneron Pharmaceuticals、Alnylam Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
Market Analysis and Insights: Global Cholesterol Lowering Biologic Drugs Market
The global Cholesterol Lowering Biologic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cholesterol Lowering Biologic Drugs Scope and Market Size
Cholesterol Lowering Biologic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholesterol Lowering Biologic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cholesterol Lowering Biologic Drugs market is segmented into
For Oral Administration
Injectable Drugs
Segment by Application, the Cholesterol Lowering Biologic Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
Regional and Country-level Analysis
The Cholesterol Lowering Biologic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cholesterol Lowering Biologic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cholesterol Lowering Biologic Drugs Market Share Analysis
Cholesterol Lowering Biologic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholesterol Lowering Biologic Drugs business, the date to enter into the Cholesterol Lowering Biologic Drugs market, Cholesterol Lowering Biologic Drugs product introduction, recent developments, etc.
The major vendors covered:
Amgen
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
…
1 Study Coverage
1.1 Cholesterol Lowering Biologic Drugs Product Introduction
1.2 Market Segments
1.3 Key Cholesterol Lowering Biologic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Type
1.4.2 For Oral Administration
1.4.3 Injectable Drugs
1.5 Market by Application
1.5.1 Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Online Sales
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cholesterol Lowering Biologic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Cholesterol Lowering Biologic Drugs Revenue 2015-2026
2.1.2 Global Cholesterol Lowering Biologic Drugs Sales 2015-2026
2.2 Global Cholesterol Lowering Biologic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cholesterol Lowering Biologic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cholesterol Lowering Biologic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cholesterol Lowering Biologic Drugs Competitor Landscape by Players
3.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers
3.1.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Cholesterol Lowering Biologic Drugs Revenue by Manufacturers
3.2.1 Cholesterol Lowering Biologic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cholesterol Lowering Biologic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cholesterol Lowering Biologic Drugs Revenue in 2019
3.2.5 Global Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cholesterol Lowering Biologic Drugs Price by Manufacturers
3.4 Cholesterol Lowering Biologic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cholesterol Lowering Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cholesterol Lowering Biologic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cholesterol Lowering Biologic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cholesterol Lowering Biologic Drugs Market Size by Type (2015-2020)
4.1.1 Global Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020)
4.1.2 Global Cholesterol Lowering Biologic Drugs Revenue by Type (2015-2020)
4.1.3 Cholesterol Lowering Biologic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cholesterol Lowering Biologic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Cholesterol Lowering Biologic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cholesterol Lowering Biologic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cholesterol Lowering Biologic Drugs Market Size by Application (2015-2020)
5.1.1 Global Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020)
5.1.2 Global Cholesterol Lowering Biologic Drugs Revenue by Application (2015-2020)
5.1.3 Cholesterol Lowering Biologic Drugs Price by Application (2015-2020)
5.2 Cholesterol Lowering Biologic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Cholesterol Lowering Biologic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cholesterol Lowering Biologic Drugs by Country
6.1.1 North America Cholesterol Lowering Biologic Drugs Sales by Country
6.1.2 North America Cholesterol Lowering Biologic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Type
6.3 North America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Cholesterol Lowering Biologic Drugs by Country
7.1.1 Europe Cholesterol Lowering Biologic Drugs Sales by Country
7.1.2 Europe Cholesterol Lowering Biologic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cholesterol Lowering Biologic Drugs Market Facts & Figures by Type
7.3 Europe Cholesterol Lowering Biologic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cholesterol Lowering Biologic Drugs by Region
8.1.1 Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region
8.1.2 Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cholesterol Lowering Biologic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Cholesterol Lowering Biologic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cholesterol Lowering Biologic Drugs by Country
9.1.1 Latin America Cholesterol Lowering Biologic Drugs Sales by Country
9.1.2 Latin America Cholesterol Lowering Biologic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Type
9.3 Central & South America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cholesterol Lowering Biologic Drugs by Country
10.1.1 Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country
10.1.2 Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cholesterol Lowering Biologic Drugs Products Offered
11.1.5 Amgen Related Developments
11.2 Regeneron Pharmaceuticals
11.2.1 Regeneron Pharmaceuticals Corporation Information
11.2.2 Regeneron Pharmaceuticals Description and Business Overview
11.2.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Products Offered
11.2.5 Regeneron Pharmaceuticals Related Developments
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Corporation Information
11.3.2 Alnylam Pharmaceuticals Description and Business Overview
11.3.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Products Offered
11.3.5 Alnylam Pharmaceuticals Related Developments
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cholesterol Lowering Biologic Drugs Products Offered
11.1.5 Amgen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cholesterol Lowering Biologic Drugs Market Estimates and Projections by Region
12.1.1 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Cholesterol Lowering Biologic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Cholesterol Lowering Biologic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Cholesterol Lowering Biologic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Cholesterol Lowering Biologic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Cholesterol Lowering Biologic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Cholesterol Lowering Biologic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Cholesterol Lowering Biologic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Cholesterol Lowering Biologic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cholesterol Lowering Biologic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cholesterol Lowering Biologic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cholesterol Lowering Biologic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cholesterol Lowering Biologic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Cholesterol Lowering Biologic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Cholesterol Lowering Biologic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Cholesterol Lowering Biologic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Cholesterol Lowering Biologic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cholesterol Lowering Biologic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cholesterol Lowering Biologic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cholesterol Lowering Biologic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cholesterol Lowering Biologic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cholesterol Lowering Biologic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cholesterol Lowering Biologic Drugs Market Segments
Table 2. Ranking of Global Top Cholesterol Lowering Biologic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of For Oral Administration
Table 5. Major Manufacturers of Injectable Drugs
Table 6. Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Cholesterol Lowering Biologic Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Cholesterol Lowering Biologic Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Cholesterol Lowering Biologic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Cholesterol Lowering Biologic Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Cholesterol Lowering Biologic Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Cholesterol Lowering Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Cholesterol Lowering Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholesterol Lowering Biologic Drugs as of 2019)
Table 15. Cholesterol Lowering Biologic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Cholesterol Lowering Biologic Drugs Price (2015-2020) (USD/MT)
Table 18. Cholesterol Lowering Biologic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Cholesterol Lowering Biologic Drugs Product Type
Table 20. Date of International Manufacturers Enter into Cholesterol Lowering Biologic Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Cholesterol Lowering Biologic Drugs Sales Share by Type (2015-2020)
Table 24. Global Cholesterol Lowering Biologic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Cholesterol Lowering Biologic Drugs Revenue Share by Type (2015-2020)
Table 26. Cholesterol Lowering Biologic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Cholesterol Lowering Biologic Drugs Sales Share by Application (2015-2020)
Table 29. North America Cholesterol Lowering Biologic Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Cholesterol Lowering Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Cholesterol Lowering Biologic Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Cholesterol Lowering Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Cholesterol Lowering Biologic Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Cholesterol Lowering Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Table 69. Amgen Corporation Information
Table 70. Amgen Description and Major Businesses
Table 71. Amgen Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Amgen Product
Table 73. Amgen Recent Development
Table 74. Regeneron Pharmaceuticals Corporation Information
Table 75. Regeneron Pharmaceuticals Description and Major Businesses
Table 76. Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Regeneron Pharmaceuticals Product
Table 78. Regeneron Pharmaceuticals Recent Development
Table 79. Alnylam Pharmaceuticals Corporation Information
Table 80. Alnylam Pharmaceuticals Description and Major Businesses
Table 81. Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Alnylam Pharmaceuticals Product
Table 83. Alnylam Pharmaceuticals Recent Development
Table 84. Global Cholesterol Lowering Biologic Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 85. Global Cholesterol Lowering Biologic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 86. Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 87. Global Cholesterol Lowering Biologic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 88. North America: Cholesterol Lowering Biologic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 89. North America: Cholesterol Lowering Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Europe: Cholesterol Lowering Biologic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 91. Europe: Cholesterol Lowering Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Asia Pacific: Cholesterol Lowering Biologic Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 93. Asia Pacific: Cholesterol Lowering Biologic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Latin America: Cholesterol Lowering Biologic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 95. Latin America: Cholesterol Lowering Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Middle East and Africa: Cholesterol Lowering Biologic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 97. Middle East and Africa: Cholesterol Lowering Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Market Risks
Table 101. Main Points Interviewed from Key Cholesterol Lowering Biologic Drugs Players
Table 102. Cholesterol Lowering Biologic Drugs Customers List
Table 103. Cholesterol Lowering Biologic Drugs Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholesterol Lowering Biologic Drugs Product Picture
Figure 2. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. For Oral Administration Product Picture
Figure 4. Injectable Drugs Product Picture
Figure 5. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Drug Stores
Figure 9. Online Sales
Figure 10. Cholesterol Lowering Biologic Drugs Report Years Considered
Figure 11. Global Cholesterol Lowering Biologic Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Cholesterol Lowering Biologic Drugs Sales 2015-2026 (K MT)
Figure 13. Global Cholesterol Lowering Biologic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region in 2019
Figure 16. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region in 2019
Figure 18. Global Cholesterol Lowering Biologic Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Cholesterol Lowering Biologic Drugs Revenue in 2019
Figure 20. Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type in 2019
Figure 23. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type in 2019
Figure 25. Global Cholesterol Lowering Biologic Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application in 2019
Figure 28. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application in 2019
Figure 30. North America Cholesterol Lowering Biologic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Country in 2019
Figure 33. North America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Cholesterol Lowering Biologic Drugs Market Share by Type in 2019
Figure 39. North America Cholesterol Lowering Biologic Drugs Market Share by Application in 2019
Figure 40. Europe Cholesterol Lowering Biologic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Country in 2019
Figure 43. Europe Cholesterol Lowering Biologic Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Cholesterol Lowering Biologic Drugs Market Share by Type in 2019
Figure 55. Europe Cholesterol Lowering Biologic Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Market Share by Region in 2019
Figure 60. China Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Cholesterol Lowering Biologic Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Cholesterol Lowering Biologic Drugs Market Share by Application in 2019
Figure 84. Latin America Cholesterol Lowering Biologic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Cholesterol Lowering Biologic Drugs Market Share by Type in 2019
Figure 95. Latin America Cholesterol Lowering Biologic Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Cholesterol Lowering Biologic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Cholesterol Lowering Biologic Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Cholesterol Lowering Biologic Drugs Market Share by Application in 2019
Figure 108. North America Cholesterol Lowering Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Cholesterol Lowering Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Cholesterol Lowering Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
コレステロール降下薬の世界市場（～2026年） Market Analysis and Insights: Global Cholesterol-Lowering Drugs Market The global Cholesterol-Lowering Drugs market size is projected to reach US$ 17960 million by 2026, from US$ 17440 million in 2020, at a CAGR of 2.8%% during 2021-2026. Global Cholesterol-Lowering Drugs Scope and Market Size Chole…- 生物学的薬剤の世界市場（～2026年） Market Analysis and Insights: Global Biologic Drugs Market The global Biologic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biologic Drugs Scope and Market Size Biologic Drugs market is segmented by Type, and …
- 生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- 脂質低下剤の世界市場（～2026年） Market Analysis and Insights: Global Lipid-lowering Agent Market The global Lipid-lowering Agent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lipid-lowering Agent Scope and Market Size Lipid-lowering Agent market is…
- コレステロール検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Cholesterol Testing Services Market The global Cholesterol Testing Services market size is projected to reach US$ 12340 million by 2026, from US$ 11770 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Cholesterol Testing Services Scope and Market Size…